5.28
+0.16(+3.13%)
Currency In USD
| Previous Close | 5.12 |
| Open | 5.07 |
| Day High | 5.48 |
| Day Low | 5.07 |
| 52-Week High | 6.08 |
| 52-Week Low | 2.53 |
| Volume | 2.66M |
| Average Volume | 623,379 |
| Market Cap | 429.67M |
| PE | -6 |
| EPS | -0.88 |
| Moving Average 50 Days | 4.14 |
| Moving Average 200 Days | 3.42 |
| Change | 0.16 |
If you invested $1000 in Codexis, Inc. (CDXS) 10 years ago, it would be worth $2,146.34 as of December 21, 2024 at a share price of $5.28. Whereas If you bought $1000 worth of Codexis, Inc. (CDXS) shares 5 years ago, it would be worth $311.5 as of December 21, 2024 at a share price of $5.28.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Codexis to Participate in Piper Sandler 36th Annual Healthcare Conference
GlobeNewswire Inc.
Nov 19, 2024 9:05 PM GMT
REDWOOD CITY, Calif., Nov. 19, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced the Company will attend the Piper Sandler 36th An
Codexis Unveils Pioneering Enzymatic Synthesis Data to Enable the Future Manufacturing of RNAi Therapeutics
GlobeNewswire Inc.
Nov 14, 2024 9:05 PM GMT
—Becomes first company to showcase four routes of synthesis for approved siRNA therapeutic asset— —Joint poster with Bachem demonstrates superiority of Company’s double-stranded RNA ligases compared to wild-type enzymes— —Management to host conferenc
Codexis Announces Appointment of Raymond De Vré, PhD, to Board of Directors
GlobeNewswire Inc.
Nov 12, 2024 9:05 PM GMT
REDWOOD CITY, Calif., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced the appointment of Raymond De Vré, PhD, to the Co